How to assess glomerular function and damage in humans

Journal of Hypertension

Volumn 17, Issue 3, 1999, Pages 309-317

  Rahn, Karl Heinz ^a,b   Heidenreich, Stefan ^a   Brückner, Dieter ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

Albuminuria; Glomerular filtration rate; Inulin clearance; Proteinuria; Renal function

Indexed keywords

CREATININE; EDETATE CHROMIUM CR 51; INULIN; IOHEXOL; IOTALAMIC ACID I 125; PENTETATE TECHNETIUM TC 99M;

CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG URINE LEVEL; GLOMERULUS; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; INULIN CLEARANCE; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; PATIENT MONITORING; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEINURIA; REVIEW;

EID: 0033013390     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917030-00002     Document Type: Review

References (82)

1. 1 Levey AS. Measurement of renal function in chronic renal disease. Kidney Int 1990; 38:167-184.
2. 2 Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241:F85-F93.
3. 3 Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77:1993-2000.
4. 4 Perrone RD. Means of clinical evaluation of renal disease progression. Kidney Int 1992; 41 (suppl 36):S26-S32.
5. 5 White RP, Samson FG, Kan L. Determination of inulin in plasma and urine by use of anthrone. J Lab Clin Med 1954; 43:475-477.
6. 6 Kuehnle HF, Dahl VK, Schmidt FH. Fully enzymatic inulin determination in small volume samples without deproteinization. Nephron 1992; 62:104-107.
7. 7 Smith HW, Goldring W, Chasis H. The measurement of tubular excretory mass, effective blood flow and filtration rate in the normal human kidney. J Clin Invest 1938; 17:263-270.
8. 8 Levey AS. Use of measurements of GFR to assess the progression of renal disease. Semin Nephrol 1989; 9:370-378.
9. 9 Prescott LF, McAuslane JAN, Freestone S. The concentration-dependent disposition and kinetics of inulin. Eur J Clin Pharmacol 1991; 40:619-624.
10. 10 Florijn KW, Barendregt JNM, Lentjes EGWM, Dam WV, Prodjosudjadi W, Saase JLCMV, et al. Glomerular filtration rate measurement by 'single-shot' injection of inulin. Kidney Int 1994; 46:252-259.
11. 11 Earle DP, Berliner RW. A simplified clinical procedure for measurement of glomerular filtration rate and renal plasma flow. Proc Soc Exp Biol Med 1946; 62:262-264.
12. 12 Schnurr E, Lahme W, Kuppers H. Measurement of renal clearance of inulin and PAH in the steady state without urine collecting. Clin Nephrol 1980; 13:26-29.
13. 13 Hellerstein S, Berenbom M, Alon U, Warady BA. The renal clearance and infusin clearance of inulin are similar, but not identical. Kidney Int 1993; 44:1058-1061.
14. 14 Van Acker BAC, Koomen GCM, Arisz L. Drawbacks of the constant-infusion technique for measurement of renal function. Am J Physiol 1995; 268:F543-F552.
15. 15 Broberger U. Determination of glomerular filtration rate in the newborn. Comparison between results obtained by the single injection technique without collection of urine and the standard clearance technique. Acta Paediat Scand 1973; 62:625-629.
16. 16 Rosenbaum JL, Kramer MS, Raja RM, Manchanda R, Lazaro N. Determination of inulin and p-aminohippurate clearances without urine collecting. Nephron 1973; 10:347-354.
17. 17 Müller-Suur R, Göransson M, Olsen L, Bäcklund G, Bäcklund L. Inulin single injection clearance. Microsample technique useful in children tor determination of glomerular filtration rate. Clin Physiol 1983; 3:19-27.
18. 18 Miller BF, Winkler AW. The renal excretion of endogenous creatinine in man. Comparison with exogenous creatinine and inulin. J Clin Invest 1983; 17:31-40.
19. 19 Berlyne GM, Varley H, Nilwarangkur S, Hoerni M. Endogenous creatinine clearance and glomerular filtration rate. Lancet 1964; ii:874-876.
20. 20 Dubb JW, Stote RM, Familiar RG. Effect of cimetidine on renal function in normal man. Clin Pharmacol Ther 1978; 24:76-83.
21. 21 Berglund F, Killander J, Pompeius R. Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man. J Urol 1975; 114:802-805.
22. 22 Shemmesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28:830-838.
23. 23 Van Acker BAC, Koomen GCM, Koopman MG, De Waart DR, Arisz L. Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet 1992; 340:1326-1329.
24. 24 Roubenoff R, Drew H, Moyer M, Petri M, Whiting-O'Keefe Q, Hellmann DB. Oral cimetidine improves the accuracy and precision of creatinine clearance in lupus nephritis. Ann Intern Med 1989; 113:501-506.
25. 25 Hilbrands LB, Artz MA, Wetzels JFM, Koene RAP. Cimetidine improves the reliability of creatinine as a marker of glomerular filtration. Kidney Int 1991; 40:1171-1176.
26. 26 Mitch WE, Collier VU, Walser M. Creatinine metabolism in chronic renal failure. Clin Sci 1980; 58:327-335.
27. 27 Mandell EE, Jones FL. Studies in nonprotein nitrogen: III. Evaluation of methods measuring creatinine. J Lab Clin Med 1953; 41:323-328.
28. 28 Doolan PD, Alpen EL, Theil GB. A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med 1962; 32:65-72.
29. 29 Young DS, Pestaner L, Gibberman V. Effects of drugs on clinical laboratory tests. Clin Chem 1975; 21:1D-6D.
30. 30 Gerard SK, Khayam-Bashi H. Characterization of creatinine error in ketotic patients: a prospective comparison of alkaline picrate methods with an enzymatic method. Am J Clin Pathol 1985; 84:659-664.
31. 31 Lim CK, Richmond W, Robinson DP, Brown SS. Toward a definitive assay of creatinine in serum and urine: separation by high-performance liquid chromatography, J Chromatogr 1978; 145:41-47.
32. 32 Owen JA. Iggo B, Scandrett FJ, Stewart CP. The determination of creatinine in plasma or serum and in urine: a critical examination. Biochem J 1954; 58:426-428.
33. 33 Kubasik NP, Lisuzzo CW, Same DG. Multilayered film analysis: evaluation of ammonia and creatinine slides. Clin Biochem 1984; 17:15-18.
34. 34 Apple F, Bandt C, Prosch A. Creatinine clearance: enzymatic vs Jaffé determinations of creatinine in plasma and urine. Clin Chem 1986; 32:388-390.
35. 35 Hahn A, Meyer G. Über die gegenseitige Umwandlung von Kreatin und Kreatinin. Zschr Biol 1923; 78:91-117.
36. 36 Borsook H, Dubnoff JW. The hydrolysis of phosphocreatine and the origin of urinary creatinine. J Biol Chem 1974; 168:493-499.
37. 37 Bleiler RE, Schedl HP. Creatinine excretion: variability and relationships to diet and body size. J Lab Clin Med 1972; 59:945-955.
38. 38 Meyersohn M, Conrad KA, Achari R. The influence of a cooked meat meal on creatinine plasma concentration and creatinine clearance. Br J Clin Pharmacol 1983; 15:227-230.
39. 39 Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
40. 40 Walser M, Drew HH, Guldan JL. Prediction of glomerular filtration rate from serum creatinine concentration in advanced chronic renal failure. Kidney Int 1993; 44:1145-1148.
41. 41 Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Ann Rev Med 1988; 39:465-490.
42. 42 Shah BV, Levey AS. Spontaneous changes in the rate of decline in reciprocal serum creatinine: errors in predicting the progression of renal disease from extrapolation of the slope. J Am Soc Nephrol 1992; 2:1186-1191.
43. 125I-iothalamate an ideal marker for glomerular filtration? Kidney Int 1985; 27:9-16.
44. 99mTc-DTPA and inulin. Am J Kidney Dis 1990; 16:224-235.
45. 45 Boschi S, Marchesini B. High-performance liquid chromatographic method for the simultaneous determination of iothalamate and o-iodohippurate. J Chromatogr 1981; 224:139-143.
46. 51Cr-EDTA clearance. Invest Radiol 1990; 25:778-782.
47. 47 LaFrance ND, Drew HH, Walser M. Radioisotopic measurement of glomerular filtration rate in severe chronic renal failure. J Nucl Med 1988; 29:1927-1930.
48. 51Cr-labelled ethylenediaminetetra-acetate and inulin in man. Clin Sci 1984; 66:613-619.
49. 99m(Sn) DTPA preparations used for the measurement of glomerular filtration rate: concise communications. J Nucl Med 1980; 2:126-129.
50. 50 Chantler C. Barratt TM. Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid. Arch Dis Child 1972; 47:613-617.
51. 51Cr) EDTA plasma clearance. Danish Med Bull 1978; 25:181-202.
52. 52 Krutzén E, Bäck SE, Nilsson-Ehle I, Nilsson-Ehle P. Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. J Lab Clin Med 1984; 104:955-961.
53. 53 Bäck SE, Krutzén E, Nilsson-Ehle P. Contrast media as markers for glomerular filtration: a pharmacokinetic comparison of four agents. Scand J Clin Lab Invest 1988; 48:247-253.
54. 54 Nilsson-Ehle P, Grubb A. New markers for the determination of GFR: iohexol clearance and cystatin C serum concentration. Kidney Int 1994; 46 (suppl 47):S17-S19.
55. 55 Gaspari F, Perico N, Ruggenenti P, Mosconi L, Amuchastegui CS, Guerini E, et al. Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 1995; 6:257-263.
56. 56 Gaspari F, Guerini E, Perico N, Mosconi L, Ruggenenti P, Remuzzi G. Glomerular filtration rate determined from a single plasma sample after intravenous iohexol injection; is it reliable? J Am Soc Nephrol 1996; 7:2689-2693.
57. 57 Abuelo JG. Proteinuria: diagnostic principles and procedures. Ann Intern Med 1983; 98:186-191.
58. 58 Kasiske B, Keane WF. Laboratory assessment of renal disease. In: Brenner BM. Rector FC Jr (editors): The kidney. Philadelphia: WB Saunders; 1990. pp. 1151-1157.
59. 59 Hoyer JR, Seiler MW. Pathophysiology of Tamm-Horsfall protein. Kidney Int 1979; 16:279-289.
60. 60 Bienenstock J, Tomasi TB Jr. Secretory IgA in normal urine. J Clin Invest 1968; 47:1162-1171.
61. 61 Marshall SM. Screening for microalbuminuria: which measurement? Diabetic Med 1991; 8:706-711.
62. 62 Wincour PH. Microalbuminuria. Worth screening for in early morning urine samples in diabetic, hypertensive, and elderly patients. BMJ 1992; 304:1196-1197.
63. 63 Miles DW, Mogensen CE, Gunderson HJG. Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest 1970; 26:5-11.
64. 64 Sawicki PT, Heinemann L, Berger M. Comparison of methods for determination of microalbuminuria in diabetic patients. Diabetic Med 1989; 6:412-415.
65. 65 Waldmann TA, Strober W, Mogielnicki RP. The renal handling of low molecular weight proteins. J Clin Invest 1972; 51:2162-2174.
66. 66 Hoffmann W, Guder WG, A diagnostic programme for quantitative analysis of proteinuria. J Clin Chem Clin Biochem 1989; 27:589-600.
67. 67 Poortmans JR. Postexercise proteinuria in humans; facts and mechanisms. JAMA 1985; 253:236-240.
68. 68 Kyle RA, Greipp PR. Laboratory medicine series on clinical testing. 3. The laboratory investigation of monoclonal gammopathies. Maya Clin Proc 1978; 53:719-739.
69. 69 Cotran RS, Rennke HG. Anionic sites and the mechanisms of proteinuria. N Engl J Med 1983, 309:1050-1052.
70. 70 Deen WM, Bridges CR, Brenner BM, Myers BD. Hetoroporous model of glomerular size selectivity: application to normal and nephrotic humans. Am J Physiol 1985; 249:F374-F389.
71. 71 Deckort T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A, Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32:219-226.
72. 72 Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311:89-93.
73. 73 Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987, 31:673-689.
74. 74 Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, Den Ottolander GJH. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340:319-323.
75. 75 Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ 1990; 300:297-300.
76. 76 Mykkänen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects. The Insulin Resistance Atherosclerosis Study. Diabetes 1998; 47:793-800.
77. 77 Parving HH, Jensen HE, Mogensen CE, Erwin PE. Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1974; i:1190-1192.
78. 78 Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in nondiabetic subjects. Islington Diabetes Survey. Lancet 1988; ii:530-533.
79. 79 Niskanen L, Uusitupa M, Sarlund H , Siitonen O, Voutilainen E, Penttila I, et al. Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993; 33:237-243.
80. 80 Nilsson T, Svensson A, Lapidus L, Lindstedt G, Nyström E, Eggertsen R. The relations of microalbuminuria to ambulatory blood pressure and myocardial wall thickness in a population. J Int Med 1998; 244:55-59.
81. 81 Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996; 14:223-228.
82. 82 Jiang X, Srinivasan S, Radhakrishnamurthy B, Dalferes ER Jr, Bao W, Borenson GS. Microalbuminuria in young adults related to blood pressure in a biracial (black-white) population. Am J Hypertens 1994; 7:794-800.